GAGNON SECURITIES LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 143 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.

Quarter-by-quarter ownership
GAGNON SECURITIES LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$325,000
+9.8%
18,1310.0%0.12%
+47.6%
Q2 2017$296,000
+16.1%
18,131
-0.3%
0.08%
-25.5%
Q1 2017$255,000
-13.0%
18,191
-1.1%
0.11%
-12.7%
Q4 2016$293,000
-5.2%
18,399
-1.0%
0.13%
-3.8%
Q3 2016$309,000
-32.5%
18,590
-54.5%
0.13%
-38.8%
Q2 2016$458,000
+33.1%
40,897
-0.6%
0.21%
+29.7%
Q1 2016$344,000
-10.2%
41,1390.0%0.16%
-5.7%
Q4 2015$383,000
-17.5%
41,1390.0%0.18%
-22.9%
Q3 2015$464,000
-42.2%
41,139
-35.0%
0.23%
-28.6%
Q2 2015$803,000
+29.1%
63,288
-5.4%
0.32%
+54.4%
Q1 2015$622,000
-34.5%
66,917
+0.8%
0.21%
-32.5%
Q4 2014$950,000
+22.7%
66,367
-11.1%
0.30%
+17.8%
Q3 2014$774,000
-48.3%
74,612
-19.3%
0.26%
-46.5%
Q2 2014$1,496,000
-17.2%
92,438
-16.8%
0.48%
-9.9%
Q1 2014$1,806,000
+8.4%
111,118
-17.2%
0.54%
+7.4%
Q4 2013$1,666,000
+5.6%
134,276
-6.8%
0.50%
+1.6%
Q3 2013$1,578,000
+29.2%
144,080
-4.7%
0.49%
+11.3%
Q2 2013$1,221,000151,1650.44%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders